U.S. Cholesterol-Lowering Drugs 2005: Rx Market Analysis
and Switch Forecasts
Published November 2005
View
PDF brochure
An in-depth analysis of the prescription cholesterol-lowering
drug market and the potential for Rx-to-OTC switches
in this class in the United States. The study includes
a comprehensive examination of currently available OTCs
and consumer products used to help manage cholesterol
levels; an assessment of the likelihood of Rx-to-OTC
switches in this product class, including various view
points on this topic from healthcare professionals;
a review of major healthcare trends, including cost
containment of prescription drugs; and an interactive
forecasting model. (Y589)
Contact
|
